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Psoralens were first introduced into medical use
as a treatment for vitiligo 1948 as ammoidin
(8-methoxypsoralens) and ammidin (5-isoamyl-
ene oxypsoralen) which were separated from
the extract of fruits of an Egyptian herb Ammi
&tajus Linn (1). The efficiency of this group of
drugs promoting melanogenesis has been es-
tablished by many workers in this field (2—7).
From clinical observations A.M.El-Mofty (8)
(in press) reported that the supplementation
of copper as copper sulfate—given orally—to
the treatment of vitiligo with psoralen compounds
showed great improvement in repigmentation
and raised the percentage of improvement and
complete cure to 47%.
It is well established that under normal con-
ditions the process of melanin formation goes
on steadily as a result of the enzymatic activity
of tyrosinase, a copper metalo enzyme. In 1951
Lerner et al. (9) reported that copper essential
for tyrosinase activity in mammalian tissues in-
cluding human epidermis, and more recently in
1958 Breathnach (10) found that the addition of
dilute copper sulphate solution to the tyrosinase
solution leads to a speeding up of the action in
the melanocytes of both freckles and pale epi-
dermis. On the other hand it was found that
many organic sulfur compounds such as cysteine
and glutathione are active inhibitors of enzymatic
melanin formation in vivoas well as in vitro (11, 9).
It is thus evident that all factors leading to
disturbance in melanin formation could be traced
to an upset of a final balance between copper
tyrosinase and the inhibiting-SH group.
A study was carried out by A.M.El-Mofty,
Fawzy, El-Hawary (12) to investigate the bio-
chemical effects of psoralen therapy on the two
important factors controlling tyrosinase activity,
namely, the concentration and availability of
copper and—SH group (represented mainly as
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glutathione). They found that treatment with
psoralen compounds caused definite rise in serum
copper levels of both leukodermic patients and
the normal controls.
It was therefore thought of interest to explore
in detail the action of psoralens on copper metabo-
lism and glutathione levels in rats in an attempt
to determine the mode of action of the psoralens
on pigmentation. Analysis of blood and liver for
their copper and glutathione contents in experi-
mental animals receiving the psoralen derivates
was done and compared with control groups. We
tried to compare the effect of pure crystalline
psoralen, ammoidin (8-methoxy psoralen) and
ammidin (5-isoamylene oxypsoralen) to study
the effect of each drug separately since the drug
used in treatment was usually a mixture of
psoralen compounds.
EXPERIMENTAL
In this work albino rats weighing from 200 gm.
were used. Ammoidin (8-methoxypsoralen) and
ammidin (5-isoamylene oxypsoralen) were kindly
supplied by Memphis Chemical Company as pure
chemical materials.
Doses of 800 mgm./Kg. body weight of either
drug were used in the brief experiments whereas
doses of 300 mgm./Kg. body weight were used in
the longer experiments. The doses were given
orally mixed with food as an emulsion, forced-fed
with a polythene tube attached to a syringe. The
experimental period for the short experiments
was 24—48 hours and for the longer experiments it
was 16 days.
The life span of albino rat is assumed to be 3
years. This may be considered as the equivalant
of 90 years of human life (19). Sixteen days in
the life span of albino rats can be considered
equal to 16 months of human life.
At the end of the experimental period the ani-
mals were sacrificed by decapitation. The blood
was collected from the neck; and the animal
was immediately dissected and tissue (liver)
needed for experimentation was quickly removed,
washed in physiological saline, blotted against
filter paper to remove any extra fluid, then weighed
and kept in the deep freeze until it was analyzed.
645
646 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
TABLE I
Tissue copper and glutathione contents in normal
rats
Results are expressed as mg. glutathione/100
ml and as microgram Cu/l00 ml in blood and
/100 gm. fresh weight in case of tissues.
Tissue
Rat No. Meao
Value
SE.
1 2 3 4 5 6
Blood 140 122 138 126 133 127 131
Cu
Liver 131 104 110 115 121 109 115
Cu
Blood 21.2 22.2 24.6 24.3 23.5 26.8 23.8
G.S.H.
Liver 109 79.6 83.7 96 98.3 87.4 94
G.S.H.
The method for estimation of blood glutathione,
worked out by Thompson and Watson in 1952 (13),
was adopted in this work.
Tissue glutathione was estimated by the method
of El-Hawary (14).
The method of Gubler, G. J. et at. (15) for the
estimation of serum copper was followed.
For the estimation of tissue copper content the
same procedure was applied using tissues homo-
genates prepared as follows:
About one gm. of the liver was homogenized
and made up to a volume of 4.5 ml. Three ml. of
this homogenate were transfered to a conical cen-
trifuge tube (capacity 15 ml.). To it was added 3
ml. of 2N HC1. The contents were mixed well and
left to stand for 10 minutes. Then 3 ml. of 20%
trichioro acetic acid solution were added, the con-
tents again mixed well and left to stand for 10
minutes. The tubes were then centrifuged for 30
minutes at 300 r.p.m. Two and a half microgram
of the supernatant-fluid were used for the deter-
mination of copper content following the same
procedure of Cubler et at. (15).
RESULTS
The results obtained for the different rats are
noted in the following tables.
Table I shows the values obtained for tissue
copper and glutathione contents in rats receiving
no drugs.
The results obtained for blood and tissue
glutathione and copper content in rats receiving
doses of 800 mg. ammoidin/Kg. body weight in
the short experiments are given in Table II.
These figures show that administration of
ammoidin in doses of 800 mg/Kg. body weight
causes a dramatic increase in blood copper, a
normal mean value of 131 to mean value of 325
microgram %. This was associated with a marked
decrease in the liver copper content from a normal
mean value of 113 to 37 mierogram/100 gm.
fresh tissue weight.
The results are graphically represented
in Fig. 1.
Regarding the effect of brief experimentation
with ammoidin on tissue glutathione, the figures
show a marked decrease in liver glutathione
content from a normal mean value of 94 to 48
mg./100 gm. tissue fresh weight;whereas in blood,
the decrease was not great (only from a normal
mean value of 23.8 to a mean value of 20.4 mg.
glutathione/100 ml. blood). Yet in some rats (No.
1, 2, 6) the decrease in the levels of blood gluta-
thione is significant.
The results obtained from blood and liver
copper and glutathione content in rats receiving
doses of 800 mgm. ammidin/Kg. body weight in
the short experiments are given in Table III.
These figures show that the administration of
ammidin in the previously mentioned doses has
no appreciable effect on copper and glutathione
content of blood and liver.
It was thought that the results obtained in
the short experiment may not represent the
changes occurring in treating the patients with
theraputie doses of psoralen compounds. For
this reason we carried out some chronic experi-
ments using sublethal doses of ammoidin, 300
mgm./Kg. body weight daily for 16 days. The
results of these prolonged experiments are repre-
sented in Table J1/
TABLE II
Blood Liver
Rat No.
G.S.H. Cu G.S.H. Cu
1 15.2 294 — 82
2 19.8 245 35.4 46
3 20.2 403 53.2 37.4
4 26.4 217 37.1 36.2
5 20.2 392 48.6 74.7
6 16.8 395 64.8 66.2
7 24.0 — 53.5 —
Mean 20.4 325 48.8 37.1
S .E.
220
200
180
160
140
120
100
80
60
40
20
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No. of Rats
The Effect of Ajumidin on
Blood
G.S.H. Cu
Liver
G.S.E. Cu
1
2
3
4
5
6
Mean S.E.
18.8
21.2
21.2
20.3
18.4
20.5
19.7
—
112
112
108
115
113
112
72.4
68.2
74.6
73.4
71.2
74.6
72.4
110
121
101
103
116
115
111
From the data given in Table IV it is clear
that prolonged doses of ammoidin (8-methoxy-
psoralen) have almost the same effect as the
doses of the shorter ammoidin treatment. There
No. of Rats
Blood Liver
G.S.H. Cu G.S.H. Cu
1
2
3
4
5
6
Mean S.E.
26
29.2
24.3
30.8
25.2
29.6
27.4
433
315
344
275
357
325
341
107
—
78
115
94
106
100
120
120
86
59
57
62
84.5
is again a huge rise in blood coppr from a normal
mean value of 131 to a mean value of 341 micro-
gram%, and this was associated with a decrease
in the level of liver copper from normal value of
115 to 84.5 mg./100 gm. tissue fresh weight. The
Liver Copper360
340
320
300
280
260
240
Blood Copper
325 After
Ammoidin
Normal
Fio. 1. Effect of Ammoidin on copper levels. Rat
TABLE III TABLE IV
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360
340
320
300
280
260
240
220
200
180
160
140
120
100
80
60
40
20
0
latter decrease is less dramatic than the decrease
occurring in the short ammoidin course of treat-
ment.
On the other hand, the effect of prolonged
doses of ammoidin on blood and tissue glutathi-
one is less than the corresponding effect in
the shorter course dosage.
The effect of ammoidin in prolonged doses on
tissue and blood copper and glutathione is
graphically represented in Fig. 2.
DISCUSSION
The findings show beyond any reasonable
doubt that ammoidin (8-methoxy psoralen) is a
strong hyper-cupremic agent and that it leads
to elevation of blood copper through mobilization
of liver stores of copper.
This was demonstrated in both the short and
the prolonged experiments. Ammidin (5-iso-
amylene oxypsoralen) is completely inert and
has no effect at all on copper or glutathione levels
in blood or liver.
With regard to the effect on —811 group, it
appears that the blood changes are not striking.
If the changes are compared to changes in blood
copper one is tempted to relate the therapeutic
value to its effect on blood copper rather than its
effect on —Sil group.
The explanation of hepatic depletion of —511
group under the effect of psoralens is not clear.
We are tempted to suggest that the cause is
disruption of glutathione rather than its mobi-
lization from liver since no striking elevation of
—SU level in the blood was obtained. The doses
used in both experiments are far above maximum
therapeutic effective doses. This was intended to
accentuate the changes for purposes of demon-
Blood Copper
341 After
Ammoidin
Liver Copper
Normal
131 Normal
FIG. 2
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by Memphis Chemical Co., Cairo, Egypt to whom
we are grateful.
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stration. The theraputic doses in man (12) lead
to definite rise in blood copper levels.
The mechanism by which psoralens mobilize
copper from liver to blood was in urgent need
of investigation not only to elucidate the mode
of action, but also to exclude the possibility that
copper is mobilized as a result of a direct toxic
effect on the liver by the drug. The results are
going to be reported in the following paper. But
it suffices here to report that the drug loses
completely its mobilizing effect on copper (from
liver to blood) in hypophysectomized animals.
This excludes completely a direct toxic effect on
the liver, causing cellular disruption and mobi-
lization and escape of copper to blood.
Keeping in mind the importance of copper and
copper tyrosinase in melanogenesis, the elevation
of blood copper under ammoidin might throw
light on its mode of action and its therapeutic
value in promotion of repigmentation in
leukoderma.
SUMMARY AND CONCLUSION
1. Ammoidin (8-methoxy psoralen) causes
marked rise of blood copper levels and drop of
copper contents of liver in rats in both short and
prolonged experiments.
2. Ammidin (5-isoamylene oxypsoralen)
showed no similar effects.
3. Ammoidin, in doses given, shows a drop of
glutathione content of liver. Blood glutathione
showed no demonstrable change after ammoidin.
4. It is suggested that the blood copper-raising
effect of aminoidin might elucidate the mode of
action in melanogenesis. Blood glutathione
changes under ammoidin are so slight as to allow
the assumption that their drop might be a con-
tributing factor in repigmentation.
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